Blackstone Life Sciences VI L.P. — Form D

Blackstone Life Sciences VI L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-12-17. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Tabea G HsiExecutive OfficerNew York, NY
Eric LiawRelated PersonNew York, NY
Christopher StrianoRelated PersonNew York, NY
Joseph BarattaExecutive OfficerNew York, NY
Joseph BarattaRelated PersonNew York, NY
Alicia NovakExecutive OfficerNew York, NY
Alicia NovakRelated PersonNew York, NY
Chris G PlaccaExecutive OfficerNew York, NY
Nentcho G NentchevExecutive OfficerNew York, NY
n/a BXLS VI L.L.C.PromoterNew York, NY
n/a BXLS VI L.L.C.Related PersonNew York, NY
Mathias G FavettoExecutive OfficerNew York, NY
Elsa G GelinExecutive OfficerNew York, NY
n/a Blackstone Life Sciences Associates VI L.P.PromoterNew York, NY
n/a Blackstone Life Sciences Associates VI L.P.Related PersonNew York, NY
Victoria G PortnoyExecutive OfficerNew York, NY
Nicholas G GalakatosExecutive OfficerNew York, NY
Robert G LiptakExecutive OfficerNew York, NY
Nentcho NentchevRelated PersonNew York, NY
Omar RehmanRelated PersonNew York, NY
Natacha G JamarExecutive OfficerNew York, NY
Julie ConstableExecutive OfficerNew York, NY
Robert LiptakRelated PersonNew York, NY
Nicholas GalakatosRelated PersonNew York, NY
Christopher G StrianoExecutive OfficerNew York, NY

Other filings by this issuer (4)

FiledFormOfferingSold
2026-04-02D/A$6.3B$6.3B
2025-12-09D/A$3.6B
2025-10-08D/A$3.3B
2025-04-23D/A$1.8B

More